Rogaratinib (BAY1163877) Human Mass Balance Study
Clinical trial NCT03484585 · COMPLETED
Trial details
- NCT number
- NCT03484585
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-06
- Primary completion
- 2018-05-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.